Skip to main content
SpringerLink
Log in

Reduced H3K27me3 levels in diffuse gliomas: association with 1p/19q codeletion and difference from H3K27me3 loss in malignant peripheral nerve sheath tumors

  • Original Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

Trimethylation of histone H3 at lysine 27 (H3K27me3) acts as a transcriptional repressor of target genes. Recent immunohistochemical studies have reported a loss of H3K27me3 modification in diffuse (especially 1p/19q-codeleted) gliomas. However, we did not observe H3K27me3 loss in diffuse gliomas using routine immunostaining conditions for the detection of H3K27me3 loss in malignant peripheral nerve sheath tumors (MPNSTs). Therefore, we conducted immunohistochemical analysis of surgically resected specimens to understand the differences in the H3K27me3 status in MPNSTs and diffuse gliomas and evaluate the diagnostic utility of H3K27me3 immunohistochemistry. Staining with a standard 1:200 dilution of the C36B11 antibody showed a complete loss of H3K27me3 in 5 out of 11 MPNSTs, whereas most diffuse gliomas (149/151, 98.7%) showed diffuse immunoreactivity. At a 1:2000 antibody dilution, 12.6% (19/151) of the diffuse gliomas showed H3K27me3 loss, which was significantly associated with 1p/19q codeletion (P < 0.001). H3K27me3 loss predicted 1p/19q codeletion in IDH-mutant gliomas with lower sensitivity (56.2%) and higher specificity (100%) than ATRX retention or p53 negative result. In conclusion, reduction in H3K27me3 levels was associated with 1p/19q codeletion in diffuse gliomas; however, the extent of reduction differed from that in MPNSTs, and the results depended on the immunostaining conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Baylin SB, Jones PA (2016) Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol 8:a019505

    Article  Google Scholar 

  2. Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8:286–298

    Article  CAS  Google Scholar 

  3. Shen H, Laird PW (2013) Interplay between the cancer genome and epigenome. Cell 153:38–55

    Article  CAS  Google Scholar 

  4. Lee W, Teckie S, Wiesner T et al (2014) PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet 46:1227–1232

    Article  CAS  Google Scholar 

  5. Zhang M, Wang Y, Jones S et al (2014) Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors. Nat Genet 46:1170–1172

    Article  CAS  Google Scholar 

  6. Prieto-Granada CN, Wiesner T, Messina JL et al (2016) Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST. Am J Surg Pathol 40:479–489

    Article  Google Scholar 

  7. Schaefer IM, Fletcher CD, Hornick JL (2016) Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics. Mod Pathol 29:4–13

    Article  CAS  Google Scholar 

  8. Bender S, Tang Y, Lindroth AM et al (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24:660–672

    Article  CAS  Google Scholar 

  9. Venneti S, Garimella MT, Sullivan LM et al (2013) Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas. Brain Pathol 23:558–564

    Article  CAS  Google Scholar 

  10. Bayliss J, Mukherjee P, Lu C et al (2016) Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas. Sci Transl Med 8:366ra161

    Article  Google Scholar 

  11. Panwalkar P, Clark J, Ramaswamy V et al (2017) Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome. Acta Neuropathol 134:705–714

    Article  CAS  Google Scholar 

  12. Hasselblatt M, Johann PD, Kool M, Fruhwald MC (2017) Reduced histone H3 K27 trimethylation is encountered in about 50% of atypical teratoid/rhabdoid tumors (AT/RT) but is not associated with molecular subgroup status and outcome. Acta Neuropathol 134:817–818

    Article  CAS  Google Scholar 

  13. Kakkar A, Biswas A, Goyal N et al (2016) The Expression of Cyclin D1, VEGF, EZH2, and H3K27me3 in atypical teratoid/rhabdoid tumors of the CNS: a possible role in targeted therapy. Appl Immunohistochem Mol Morphol 24:729–737

    Article  CAS  Google Scholar 

  14. Katz LM, Hielscher T, Liechty B et al (2018) Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol 135:955–963

    Article  CAS  Google Scholar 

  15. Filipski K, Braun Y, Zinke J et al (2019) Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas. Acta Neuropathol 138:331–334

    Article  Google Scholar 

  16. Pekmezci M, Phillips JJ, Dirilenoglu F et al (2020) Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker. Acta Neuropathol 139:597–600

    Article  Google Scholar 

  17. Aihara K, Mukasa A, Nagae G et al (2017) Genetic and epigenetic stability of oligodendrogliomas at recurrence. Acta Neuropathol Commun 5:18

    Article  Google Scholar 

  18. Arita H, Yamasaki K, Matsushita Y et al (2016) A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun 4:79

    Article  Google Scholar 

  19. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2016) WHO Classification of Tumours of the Central Nervous System. International Agency for Research on Cancer

  20. Takami H, Yoshida A, Fukushima S et al (2015) Revisiting TP53 mutations and immunohistochemistry—a comparative study in 157 diffuse gliomas. Brain Pathol 25:256–265

    Article  CAS  Google Scholar 

  21. Ikemura M, Shibahara J, Mukasa A et al (2016) Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas. Histopathology 69:260–267

    Article  Google Scholar 

  22. Feller C, Felix M, Weiss T et al (2020) Histone epiproteomic profiling distinguishes oligodendroglioma, IDH-mutant and 1p/19q co-deleted from IDH-mutant astrocytoma and reveals less tri-methylation of H3K27 in oligodendrogliomas. Acta Neuropathol 139:211–213

    Article  CAS  Google Scholar 

  23. Jain SU, Do TJ, Lund PJ et al (2019) PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism. Nat Commun 10:2146

    Article  Google Scholar 

  24. Lu C, Ward PS, Kapoor GS et al (2012) IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483:474–478

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Editage (www.editage.com) for English language editing.

Author information

Author notes

  1. Keiichiro Kitahama and Shohei Iijima contributed equally to this work.

Authors and Affiliations

  1. Department of Pathology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan

    Keiichiro Kitahama, Ayumi Sumiishi, Akimasa Hayashi, Kiyotaka Nagahama & Junji Shibahara

  2. Department of Neurosurgery, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan

    Shohei Iijima, Kuniaki Saito, Nobuyoshi Sasaki, Keiichi Kobayashi, Saki Shimizu & Motoo Nagane

Authors
  1. Keiichiro Kitahama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shohei Iijima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ayumi Sumiishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Akimasa Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kiyotaka Nagahama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kuniaki Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nobuyoshi Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Keiichi Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Saki Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Motoo Nagane
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Junji Shibahara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Junji Shibahara.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 113 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kitahama, K., Iijima, S., Sumiishi, A. et al. Reduced H3K27me3 levels in diffuse gliomas: association with 1p/19q codeletion and difference from H3K27me3 loss in malignant peripheral nerve sheath tumors. Brain Tumor Pathol 38, 23–29 (2021). https://doi.org/10.1007/s10014-020-00382-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10014-020-00382-y

Keywords

Search

Navigation